IDEX Financials
IDEX (IEX) reported $3.5B in revenue for fiscal year 2025, up 5.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
IDEX runs as a high-cash-conversion industrial platform whose stable product economics fund acquisitions, payouts, and balance-sheet flexibility.
From FY2023 to FY2025, gross margin barely moved from44.2% to44.5% while operating margin slipped from22.4% to20.2% , showing the pressure came above the gross-profit line in overhead and amortization rather than in core product economics. The fact that FY2025 free cash flow still exceeded net income at$616.8M versus$483.2M means that weaker reported earnings translated into less damage to cash generation than the income statement alone suggests.
The balance sheet is acquisition-shaped: goodwill reached
FY2025 shows low capital intensity: capex was only
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of IDEX's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
IDEX has an operating margin of 20.2%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 90/100, reflecting efficient cost management and pricing power. This is down from 20.7% the prior year.
IDEX's revenue grew 5.8% year-over-year to $3.5B, a solid pace of expansion. This earns a growth score of 41/100.
IDEX has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 39/100.
With a current ratio of 2.86, IDEX holds $2.86 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 75/100.
IDEX converts 17.8% of revenue into free cash flow ($616.8M). This strong cash generation earns a score of 85/100.
IDEX earns a strong 12.0% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is down from 13.3% the prior year.
IDEX scores 5.44, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($17.0B) relative to total liabilities ($2.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
IDEX passes 8 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, IDEX generates $1.41 in operating cash flow ($680.4M OCF vs $483.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
IDEX generated $3.5B in revenue in fiscal year 2025. This represents an increase of 5.8% from the prior year.
IDEX's EBITDA was $905.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.2% from the prior year.
IDEX reported $483.2M in net income in fiscal year 2025. This represents a decrease of 4.3% from the prior year.
IDEX earned $6.41 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 3.5% from the prior year.
Cash & Balance Sheet
IDEX generated $616.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 2.3% from the prior year.
IDEX held $580.0M in cash against $1.8B in long-term debt as of fiscal year 2025.
IDEX paid $2.84 per share in dividends in fiscal year 2025. This represents an increase of 2.9% from the prior year.
Margins & Returns
IDEX's gross margin was 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
IDEX's operating margin was 20.2% in fiscal year 2025, reflecting core business profitability. This is down 0.5 percentage points from the prior year.
IDEX's net profit margin was 14.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.5 percentage points from the prior year.
IDEX's ROE was 12.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.3 percentage points from the prior year.
Capital Allocation
IDEX invested $70.0M in research and development in fiscal year 2025. This represents an increase of 3.9% from the prior year.
IDEX spent $247.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
IDEX invested $63.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 2.3% from the prior year.
IEX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.5B+5.8% | $3.3B-0.2% | $3.3B+2.9% | $3.2B+15.1% | $2.8B+17.6% | $2.4B-5.7% | $2.5B+0.4% | $2.5B+8.6% | $2.3B+8.2% | $2.1B+4.6% | $2.0B-5.9% | $2.1B+6.1% | $2.0B+3.6% | $2.0B+6.3% | $1.8B |
| Cost of Revenue | $2.0B | $1.9B+5.2% | $1.8B-0.2% | $1.8B+4.1% | $1.8B+13.9% | $1.5B+16.3% | $1.3B-3.3% | $1.4B+0.3% | $1.4B+8.3% | $1.3B+6.6% | $1.2B+5.9% | $1.1B-6.9% | $1.2B+4.1% | $1.2B0.0% | $1.2B+4.6% | $1.1B |
| Gross Profit | $1.6B | $1.5B+6.5% | $1.4B-0.1% | $1.4B+1.4% | $1.4B+16.5% | $1.2B+19.2% | $1.0B-8.7% | $1.1B+0.6% | $1.1B+8.9% | $1.0B+10.3% | $930.8M+2.9% | $904.3M-4.7% | $949.3M+8.7% | $873.4M+8.7% | $803.7M+8.8% | $738.7M |
| R&D Expenses | N/A | $70.0M+3.9% | $67.4M-1.5% | $68.4M+11.4% | $61.4M+22.6% | $50.1M+3.9% | $48.2M-14.5% | $56.4M+17.5% | $48.0M+13.2% | $42.4M+7.6% | $39.4M+17.3% | $33.6M-8.7% | $36.8M+11.5% | $33.0M-9.3% | $36.4M+1.1% | $36.0M |
| SG&A Expenses | $848.2M | $818.8M+7.9% | $758.7M+7.8% | $703.5M+7.8% | $652.7M+12.9% | $578.2M+16.8% | $494.9M-5.7% | $525.0M-2.2% | $536.7M+2.2% | $524.9M+6.6% | $492.4M+3.8% | $474.2M-6.0% | $504.4M+5.6% | $477.9M+7.5% | $444.5M+5.4% | $421.7M |
| Operating Income | $741.7M | $699.3M+3.3% | $677.2M-7.5% | $732.5M-2.5% | $751.4M+18.0% | $637.0M+22.3% | $520.7M-10.1% | $579.0M+1.7% | $569.1M+13.2% | $502.6M+21.9% | $412.4M-5.6% | $437.0M+1.3% | $431.2M+9.0% | $395.5M+208.5% | $128.2M-57.9% | $304.7M |
| Interest Expense | N/A | N/A | N/A | $51.7M+27.0% | $40.7M-0.7% | $41.0M-8.5% | $44.8M+1.1% | $44.3M+0.4% | $44.1M-1.7% | $44.9M-1.6% | $45.6M+9.6% | $41.6M-0.6% | $41.9M-0.7% | $42.2M-0.1% | $42.3M+44.0% | $29.3M |
| Income Tax | $162.0M | $150.1M+11.4% | $134.7M-18.2% | $164.7M+1.2% | $162.7M+24.7% | $130.5M+41.1% | $92.5M-13.9% | $107.4M-9.3% | $118.4M+0.3% | $118.0M+21.2% | $97.4M-11.1% | $109.5M-3.1% | $113.1M+15.5% | $97.9M+101.6% | $48.6M-39.3% | $80.0M |
| Net Income | $519.5M | $483.2M-4.3% | $505.0M-15.3% | $596.1M+1.6% | $586.9M+30.6% | $449.4M+19.0% | $377.8M-11.2% | $425.5M+3.6% | $410.6M+21.7% | $337.3M+24.4% | $271.1M-4.1% | $282.8M+1.2% | $279.4M+9.5% | $255.2M+578.2% | $37.6M-80.6% | $193.9M |
| EPS (Diluted) | — | $6.41-3.5% | $6.64-15.4% | $7.85+1.8% | $7.71+31.1% | $5.88+19.0% | $4.94-11.2% | $5.56+5.1% | $5.29+21.3% | $4.36+23.5% | $3.53-2.5% | $3.62+4.9% | $3.45+11.7% | $3.09+586.7% | $0.45-80.6% | $2.32 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
IEX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9B+2.7% | $6.7B+15.0% | $5.9B+6.4% | $5.5B+12.1% | $4.9B+11.4% | $4.4B+15.7% | $3.8B+9.8% | $3.5B+2.2% | $3.4B+7.8% | $3.2B+12.5% | $2.8B-3.4% | $2.9B+0.8% | $2.9B+3.4% | $2.8B-1.8% | $2.8B |
| Current Assets | $1.6B+3.2% | $1.6B+10.1% | $1.4B+3.4% | $1.4B-16.6% | $1.7B+1.3% | $1.7B+31.4% | $1.3B+15.5% | $1.1B+8.8% | $1.0B+22.0% | $822.7M-4.6% | $862.7M-19.8% | $1.1B+8.6% | $991.0M+12.4% | $881.9M+11.7% | $789.2M |
| Cash & Equivalents | $580.0M-6.6% | $620.8M+16.2% | $534.3M+24.2% | $430.2M-49.7% | $855.4M-16.6% | $1.0B+62.2% | $632.6M+35.6% | $466.4M+24.1% | $375.9M+59.3% | $236.0M-28.1% | $328.0M-35.6% | $509.1M+15.8% | $439.6M+37.9% | $318.9M+38.5% | $230.3M |
| Inventory | $479.4M+11.6% | $429.7M+2.1% | $420.8M-10.6% | $470.9M+27.1% | $370.4M+27.8% | $289.9M-1.2% | $293.5M+4.8% | $280.0M+7.8% | $259.7M+2.7% | $252.9M+5.7% | $239.1M+0.6% | $237.6M+2.9% | $231.0M-1.7% | $234.9M-7.6% | $254.3M |
| Accounts Receivable | $511.9M+11.0% | $461.0M+10.0% | $419.0M-2.9% | $431.3M+21.5% | $354.9M+23.1% | $288.3M-3.3% | $298.1M-5.0% | $313.7M0.0% | $313.7M | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $3.4B+5.0% | $3.3B+14.6% | $2.8B+7.6% | $2.6B+21.7% | $2.2B+14.4% | $1.9B+6.5% | $1.8B+4.8% | $1.7B-0.4% | $1.7B+4.4% | $1.6B+16.9% | $1.4B+5.7% | $1.3B-2.1% | $1.3B+2.1% | $1.3B-7.7% | $1.4B |
| Total Liabilities | $2.9B-1.7% | $3.0B+27.0% | $2.3B-6.0% | $2.5B+16.9% | $2.1B+12.8% | $1.9B+20.9% | $1.6B+4.8% | $1.5B-2.2% | $1.5B-6.1% | $1.6B+18.3% | $1.4B-3.9% | $1.4B+7.8% | $1.3B-0.4% | $1.3B-0.2% | $1.3B |
| Current Liabilities | $575.4M-8.6% | $629.7M+25.9% | $500.3M-8.0% | $543.6M+13.3% | $480.0M+20.3% | $399.0M+11.5% | $357.9M-1.9% | $364.7M+1.0% | $361.0M+16.8% | $309.2M-0.1% | $309.6M-24.8% | $412.0M+35.2% | $304.6M+4.5% | $291.4M+12.8% | $258.3M |
| Long-Term Debt | $1.8B-2.1% | $1.9B+40.3% | $1.3B-9.8% | $1.5B+23.4% | $1.2B+14.0% | $1.0B+23.0% | $848.9M+0.1% | $848.3M-1.2% | $858.8M-15.3% | $1.0B+20.8% | $839.7M+10.4% | $760.4M-1.5% | $772.0M-0.9% | $779.2M-3.4% | $806.4M |
| Total Equity | $4.0B+6.1% | $3.8B+7.2% | $3.5B+16.5% | $3.0B+8.4% | $2.8B+10.3% | $2.5B+12.2% | $2.3B+13.5% | $2.0B+5.7% | $1.9B+22.2% | $1.5B+7.0% | $1.4B-2.9% | $1.5B-5.5% | $1.6B+7.4% | $1.5B-3.2% | $1.5B |
| Retained Earnings | $4.5B+6.4% | $4.2B+7.5% | $3.9B+11.4% | $3.5B+13.0% | $3.1B+10.0% | $2.8B+8.7% | $2.6B+11.7% | $2.3B+13.8% | $2.1B+12.2% | $1.8B+10.1% | $1.7B+12.3% | $1.5B+14.7% | $1.3B+16.2% | $1.1B-2.5% | $1.1B |
IEX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $716.7M | $680.4M+1.8% | $668.1M-6.8% | $716.7M+28.6% | $557.4M-1.4% | $565.3M-0.7% | $569.3M+7.8% | $528.1M+10.2% | $479.3M+10.8% | $432.8M+8.2% | $399.9M+11.0% | $360.3M-2.1% | $368.0M-8.4% | $401.5M+23.1% | $326.2M+50.1% | $217.2M |
| Capital Expenditures | $75.2M | $63.6M-2.3% | $65.1M-27.6% | $89.9M+32.2% | $68.0M-6.5% | $72.7M+40.9% | $51.6M+1.4% | $50.9M-9.3% | $56.1M+27.9% | $43.9M+14.7% | $38.2M-12.6% | $43.8M-8.8% | $48.0M+52.2% | $31.5M-11.9% | $35.8M+1.8% | $35.2M |
| Free Cash Flow | $641.5M | $616.8M+2.3% | $603.0M-3.8% | $626.8M+28.1% | $489.4M-0.6% | $492.6M-4.8% | $517.7M+8.5% | $477.2M+12.7% | $423.3M+8.8% | $388.9M+7.5% | $361.7M+14.3% | $316.5M-1.1% | $320.0M-13.5% | $370.0M+27.4% | $290.4M+59.5% | $182.1M |
| Investing Cash Flow | -$155.8M | -$137.6M+86.3% | -$1.0B-254.7% | -$283.8M+69.1% | -$917.2M-31.4% | -$698.1M-304.5% | -$172.6M-26.0% | -$137.0M-68.2% | -$81.4M-48.7% | -$54.7M+89.2% | -$509.2M-141.9% | -$210.5M-191.3% | -$72.3M-6.0% | -$68.2M+35.2% | -$105.3M+77.6% | -$469.5M |
| Financing Cash Flow | -$491.5M | -$632.6M-235.8% | $465.9M+235.2% | -$344.7M-811.9% | -$37.8M-297.9% | -$9.5M+77.7% | -$42.6M+81.3% | -$227.6M+21.5% | -$290.0M-4.5% | -$277.4M-696.0% | $46.5M+115.8% | -$295.5M-60.6% | -$184.1M+16.0% | -$219.0M-60.5% | -$136.5M-153.9% | $253.4M |
| Dividends Paid | $213.4M | $212.6M+3.6% | $205.3M+7.7% | $190.7M+7.5% | $177.4M+10.1% | $161.1M+6.1% | $151.8M+3.1% | $147.2M+15.5% | $127.5M+14.7% | $111.2M+8.3% | $102.7M+6.7% | $96.2M+12.2% | $85.7M+17.6% | $72.9M+13.8% | $64.1M+17.3% | $54.6M |
| Share Buybacks | $301.2M | $247.8M | $0-100.0% | $24.2M-83.7% | $148.1M | $0-100.0% | $110.3M+101.6% | $54.7M-68.5% | $173.9M+498.2% | $29.1M-49.2% | $57.3M-72.8% | $210.8M-4.1% | $219.9M+31.3% | $167.5M+87.0% | $89.6M | $0 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
IEX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.5%+0.3pp | 44.2%0.0pp | 44.2%-0.7pp | 44.8%+0.6pp | 44.3%+0.6pp | 43.7%-1.4pp | 45.1%+0.1pp | 45.0%+0.1pp | 44.9%+0.8pp | 44.0%-0.7pp | 44.8%+0.6pp | 44.2%+1.1pp | 43.1%+2.0pp | 41.1%+1.0pp | 40.2% |
| Operating Margin | 20.2%-0.5pp | 20.7%-1.7pp | 22.4%-1.2pp | 23.6%+0.6pp | 23.0%+0.9pp | 22.1%-1.1pp | 23.2%+0.3pp | 22.9%+0.9pp | 22.0%+2.4pp | 19.5%-2.1pp | 21.6%+1.5pp | 20.1%+0.5pp | 19.5%+13.0pp | 6.6%-10.0pp | 16.6% |
| Net Margin | 14.0%-1.5pp | 15.4%-2.8pp | 18.2%-0.2pp | 18.4%+2.2pp | 16.3%+0.2pp | 16.1%-1.0pp | 17.1%+0.5pp | 16.5%+1.8pp | 14.7%+1.9pp | 12.8%-1.2pp | 14.0%+1.0pp | 13.0%+0.4pp | 12.6%+10.7pp | 1.9%-8.6pp | 10.5% |
| Return on Equity | 12.0%-1.3pp | 13.3%-3.5pp | 16.8%-2.5pp | 19.3%+3.3pp | 16.0%+1.2pp | 14.9%-3.9pp | 18.8%-1.8pp | 20.6%+2.7pp | 17.9%+0.3pp | 17.6%-2.0pp | 19.6%+0.8pp | 18.8%+2.6pp | 16.2%+13.7pp | 2.6%-10.2pp | 12.8% |
| Return on Assets | 7.0%-0.5pp | 7.5%-2.7pp | 10.2%-0.5pp | 10.7%+1.5pp | 9.1%+0.6pp | 8.6%-2.6pp | 11.2%-0.7pp | 11.8%+1.9pp | 9.9%+1.3pp | 8.6%-1.5pp | 10.1%+0.5pp | 9.6%+0.8pp | 8.9%+7.5pp | 1.4%-5.5pp | 6.8% |
| Current Ratio | 2.86+0.3x | 2.53-0.4x | 2.89+0.3x | 2.57-0.9x | 3.50-0.7x | 4.15+0.6x | 3.52+0.5x | 3.00+0.2x | 2.78+0.1x | 2.66-0.1x | 2.79+0.2x | 2.61-0.6x | 3.25+0.2x | 3.030.0x | 3.06 |
| Debt-to-Equity | 0.450.0x | 0.49+0.1x | 0.37-0.1x | 0.48+0.1x | 0.420.0x | 0.410.0x | 0.38-0.1x | 0.430.0x | 0.46-0.2x | 0.66+0.1x | 0.58+0.1x | 0.510.0x | 0.490.0x | 0.530.0x | 0.53 |
| FCF Margin | 17.8%-0.6pp | 18.4%-0.7pp | 19.1%+3.8pp | 15.4%-2.4pp | 17.8%-4.2pp | 22.0%+2.9pp | 19.1%+2.1pp | 17.0%0.0pp | 17.0%-0.1pp | 17.1%+1.4pp | 15.7%+0.8pp | 14.9%-3.4pp | 18.3%+3.4pp | 14.9%+5.0pp | 9.9% |
Similar Companies
Where IDEX Ranks
Frequently Asked Questions
What is IDEX's annual revenue?
IDEX (IEX) reported $3.5B in total revenue for fiscal year 2025. This represents a 5.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is IDEX's revenue growing?
IDEX (IEX) revenue grew by 5.8% year-over-year, from $3.3B to $3.5B in fiscal year 2025.
Is IDEX profitable?
Yes, IDEX (IEX) reported a net income of $483.2M in fiscal year 2025, with a net profit margin of 14.0%.
What is IDEX's EBITDA?
IDEX (IEX) had EBITDA of $905.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does IDEX have?
As of fiscal year 2025, IDEX (IEX) had $580.0M in cash and equivalents against $1.8B in long-term debt.
What is IDEX's gross margin?
IDEX (IEX) had a gross margin of 44.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is IDEX's operating margin?
IDEX (IEX) had an operating margin of 20.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is IDEX's net profit margin?
IDEX (IEX) had a net profit margin of 14.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does IDEX pay dividends?
Yes, IDEX (IEX) paid $2.84 per share in dividends during fiscal year 2025.
What is IDEX's return on equity (ROE)?
IDEX (IEX) has a return on equity of 12.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is IDEX's free cash flow?
IDEX (IEX) generated $616.8M in free cash flow during fiscal year 2025. This represents a 2.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is IDEX's operating cash flow?
IDEX (IEX) generated $680.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are IDEX's total assets?
IDEX (IEX) had $6.9B in total assets as of fiscal year 2025, including both current and long-term assets.
What are IDEX's capital expenditures?
IDEX (IEX) invested $63.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does IDEX spend on research and development?
IDEX (IEX) invested $70.0M in research and development during fiscal year 2025.
What is IDEX's current ratio?
IDEX (IEX) had a current ratio of 2.86 as of fiscal year 2025, which is generally considered healthy.
What is IDEX's debt-to-equity ratio?
IDEX (IEX) had a debt-to-equity ratio of 0.45 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is IDEX's return on assets (ROA)?
IDEX (IEX) had a return on assets of 7.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is IDEX's Altman Z-Score?
IDEX (IEX) has an Altman Z-Score of 5.44, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is IDEX's Piotroski F-Score?
IDEX (IEX) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are IDEX's earnings high quality?
IDEX (IEX) has an earnings quality ratio of 1.41x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is IDEX?
IDEX (IEX) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.